Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Lapatinib | 1 | uM | 10 | 156.25 | 66.59 | 370.00 | 347.75 | 1.0640 | 1.0527 |
Hs 578T | Lapatinib | 0.31623 | uM | 10 | 156.25 | 66.59 | 363.00 | 347.75 | 1.0439 | 1.0363 |
Hs 578T | Erlotinib | 10 | uM | 10 | 156.25 | 66.59 | 295.00 | 347.75 | 0.8483 | 0.8667 |
Hs 578T | Erlotinib | 19.9526 | uM | 10 | 156.25 | 66.59 | 267.00 | 347.75 | 0.7678 | 0.7902 |
Hs 578T | 17-AAG | 0.0016596 | uM | 10 | 156.25 | 66.59 | 378.00 | 347.75 | 1.0870 | 1.0712 |
Hs 578T | 17-AAG | 10 | uM | 10 | 156.25 | 66.59 | 77.00 | 347.75 | 0.2214 | 0.0628 |
Hs 578T | Linsitinib | 0.01 | uM | 10 | 156.25 | 66.59 | 371.00 | 347.75 | 1.0669 | 1.0550 |
Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 337.00 | 347.75 | 0.9691 | 0.9738 | |
Hs 578T | Linsitinib | 10 | uM | 10 | 156.25 | 66.59 | 305.00 | 347.75 | 0.8771 | 0.8930 |
Hs 578T | Linsitinib | 19.9526 | uM | 10 | 156.25 | 66.59 | 229.00 | 347.75 | 0.6585 | 0.6786 |
Hs 578T | Erlotinib | 0.31623 | uM | 10 | 156.25 | 66.59 | 410.00 | 347.75 | 1.1790 | 1.1430 |
Hs 578T | 17-AAG | 0.0033113 | uM | 10 | 156.25 | 66.59 | 510.00 | 347.75 | 1.4666 | 1.3484 |
Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 356.00 | 347.75 | 1.0237 | 1.0198 | |
Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 322.00 | 347.75 | 0.9260 | 0.9365 | |
Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 438.00 | 347.75 | 1.2595 | 1.2032 | |
Hs 578T | 17-AAG | 0.01 | uM | 10 | 156.25 | 66.59 | 161.00 | 347.75 | 0.4630 | 0.4481 |
Hs 578T | 17-AAG | 0.31623 | uM | 10 | 156.25 | 66.59 | 89.00 | 347.75 | 0.2559 | 0.1294 |
Hs 578T | 17-AAG | 0.1 | uM | 10 | 156.25 | 66.59 | 96.00 | 347.75 | 0.2761 | 0.1658 |
Hs 578T | Erlotinib | 0.031623 | uM | 10 | 156.25 | 66.59 | 257.00 | 347.75 | 0.7390 | 0.7618 |
Hs 578T | Erlotinib | 1 | uM | 10 | 156.25 | 66.59 | 406.00 | 347.75 | 1.1675 | 1.1342 |
Hs 578T | Linsitinib | 0.31623 | uM | 10 | 156.25 | 66.59 | 306.00 | 347.75 | 0.8799 | 0.8956 |
Hs 578T | Lapatinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 363.00 | 347.75 | 1.0439 | 1.0363 |
Hs 578T | 17-AAG | 0.031623 | uM | 10 | 156.25 | 66.59 | 101.00 | 347.75 | 0.2904 | 0.1909 |
Hs 578T | Erlotinib | 0.1 | uM | 10 | 156.25 | 66.59 | 357.00 | 347.75 | 1.0266 | 1.0221 |
Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 376.00 | 347.75 | 1.0812 | 1.0666 |